Clinical Trials Arena on MSN
Kamada enrols first subject in Cytogam trial for CMV infection
The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.
Post Marketing Study to Evaluate the Role of CYTOGAM in the Reduction of Risk of Late CMV Disease Following the Conclusion of ...
Laura Gibson is an associate professor of medicine and of pediatrics at UMass Chan Medical School. CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in ...
“Why didn’t anyone tell me about this virus?” is a frequent response I hear from parents upon learning their newborn is infected with cytomegalovirus or CMV. Although more than half of the U.S.
GlobalData on MSN
Moderna scraps mRNA vaccine in congenital CMV on Phase III failure
While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients will continue.
Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.
Cytomegalovirus (CMV) is a common virus that most adults are exposed to at some point in their lives, and over half of American adults have been infected by age 40. A healthy immune system can keep ...
VANCOUVER, British Columbia—Cytomegalovirus (CMV) infection in kidney or kidney/pancreas transplant recipients occurs more frequently when alemtuzumab is used for induction instead of antithymocyte ...
DelveInsight's "Cytomegalovirus Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cytomegalovirus (CMV) Infection, historical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results